Table 2.
% of cells staining | Number of women | Number of deaths |
Adjusted HR (95% CI) |
|
---|---|---|---|---|
Model 1 a | Model 2 b | |||
Overall |
|
|
|
|
<1 (ER-negative) |
506 |
157 |
Referent |
Referent |
≥1 (ER-positive) |
698 |
115 |
0.53 (0.41 to 0.68) |
0.64 (0.48 to 0.85) |
1 to 39 |
117 |
27 |
0.81 (0.53 to 1.24) |
0.93 (0.60 to 1.43) |
40 to 59 |
118 |
18 |
0.55 (0.34 to 0.91) |
0.66 (0.39 to 1.12) |
60 to 79 |
193 |
31 |
0.50 (0.33 to 0.74) |
0.57 (0.38 to 0.88) |
80 to 100 |
270 |
39 |
0.43 (0.30 to 0.62) |
0.52 (0.35 to 0.78) |
Trend |
|
|
Ptrend <0.0001 |
Ptrend = 0.0003 |
Trend in women with ER-positive tumors only |
|
|
Ptrend = 0.004 |
Ptrend = 0.006 |
Per 10% increase |
|
|
0.92 (0.89 to 0.95) |
0.94 (0.91 to 0.97) |
Per 10% increase in women with ER-positive tumors only |
|
|
0.91 (0.84 to 0.99) |
0.91 (0.84 to 0.99) |
White women |
|
|
|
|
<1 (ER-negative) |
251 |
69 |
Referent |
Referent |
≥1 (ER-positive) |
430 |
62 |
0.42 (0.29 to 0.61) |
0.56 (0.36 to 0.87) |
1 to 39 |
75 |
18 |
0.81 (0.46 to 1.43) |
1.04 (0.57 to 1.91) |
40 to 59 |
66 |
10 |
0.46 (0.22 to 0.94) |
0.65 (0.30 to 1.43) |
60 to 79 |
123 |
17 |
0.37 (0.21 to 0.66) |
0.47 (0.25 to 0.86) |
80 to 100 |
166 |
17 |
0.28 (0.16 to 0.50) |
0.39 (0.21 to 0.73) |
Trend |
|
|
Ptrend <0.0001 |
Ptrend = 0.0004 |
Trend in women with ER-positive tumors only |
|
|
Ptrend = 0.001 |
Ptrend = 0.002 |
Per 10% increase |
|
|
0.88 (0.84 to 0.93) |
0.91 (0.86 to 0.96) |
Per 10% increase in women with ER-positive tumors only |
|
|
0.85 (0.76 to 0.96) |
0.86 (0.76 to 0.96) |
Black women |
|
|
|
|
<1 (ER-negative) |
255 |
88 |
Referent |
Referent |
≥1 (ER-positive) |
268 |
53 |
0.56 (0.39 to 0.81) |
0.62 (0.42 to 0.94) |
1 to 39 |
42 |
9 |
0.56 (0.28 to 1.15) |
0.63 (0.30 to 1.29) |
40 to 59 |
52 |
8 |
0.50 (0.24 to 1.06) |
0.55 (0.25 to 1.21) |
60 to 79 |
70 |
14 |
0.60 (0.33 to 1.08) |
0.65 (0.35 to 1.21) |
80 to 100 |
104 |
22 |
0.56 (0.34 to 0.93) |
0.64 (0.37 to 1.10) |
Trend |
|
|
Ptrend = 0.007 |
Ptrend = 0.06 |
Trend in women with ER-positive tumors only |
|
|
Ptrend = 0.54 |
Ptrend = 0.67 |
Per 10% increase |
|
|
0.94 (0.90 to 0.98) |
0.95 (0.91 to 1.00) |
Per 10% increase in women with ER-positive tumors only |
|
|
0.98 (0.85 to 1.12) |
1.00 (0.87 to 1.14) |
Homogeneity between white women and black women | ||||
ER-positive versus ER-negative |
|
|
Phomogeneity = 0.56 |
Phomogeneity = 0.55 |
Trend |
|
|
Phomogeneity = 0.13 |
Phomogeneity = 0.12 |
Trend in women with ER-positive tumors only |
|
|
Phomogeneity = 0.05 |
Phomogeneity = 0.02 |
Per 10% increase |
|
|
Phomogeneity = 0.16 |
Phomogeneity = 0.15 |
Per 10% increase in women with ER-positive tumors only | Phomogeneity = 0.06 | Phomogeneity = 0.02 |
CI, confidence interval; ER, estrogen receptor; HR, hazard ratio.
aMultivariable Cox proportional hazards regression models using age (in days) as the time metric stratified by age (in years) and adjusted for race (white, black), study site (Detroit, Los Angeles), tumor stage (localized, non-localized).
bAdditionally adjusted for histologic grade (low, intermediate, high).